Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
3.06 USD -1.29% Intraday chart for NeuroBo Pharmaceuticals, Inc. -11.05% -17.22%
Apr. 17 Sector Update: Health Care Stocks Mixed Wednesday Afternoon MT
Apr. 17 NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise MT

Evolution of the average Target Price on NeuroBo Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e85409075dda6c4c91b000402e93c._JBAeJX7YJSS-WYa3tZdgU4PGCh3mHB3H71RWA1BAMM.uuUmQO_CCMXNzAFsk5kc0A86T2kn8DsGTd4pE3gDT6CS0nExzNZV06qrKw~ece593000929998dcacc7e8510f7d26e

Analyst Recommendations on NeuroBo Pharmaceuticals, Inc.

Ladenburn Thalmann Starts NeuroBo Pharmaceuticals at Buy With $6 Price Target MT
NEUROBO PHARMACEUTICALS : HC Wainwright Adjusts Price Target on NeuroBo Pharmaceuticals to $16 From $20, Reiterates Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.06 USD
Average target price
36.5 USD
Spread / Average Target
+1,092.81%
High Price Target
48 USD
Spread / Highest target
+1,468.63%
Low Price Target
25 USD
Spread / Lowest Target
+716.99%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NeuroBo Pharmaceuticals, Inc.

Ladenburg Thalmann
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. Consensus NeuroBo Pharmaceuticals, Inc.